Molluscum Contagiosum clinical trials
The registry lists 22 studies for Molluscum Contagiosum across 6 countries. 0 are recruiting or about to start. 19 of them are mainly about Molluscum Contagiosum (how this is decided). Per ClinicalTrials.gov, last updated 2026-04-03.
Who runs them
Novan, Inc. (4) · Verrica Pharmaceuticals Inc. (3) · Combined Military Hospital Abbottabad (2) · ViroXis Corporation (1) · University of Oklahoma (1) · Centro Studi Gised (1) · University of North Carolina, Chapel Hill (1) · Dalia Mahran (1)
What is being tested here
Drugs under test in Molluscum Contagiosum studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Who these studies take
No Molluscum Contagiosum study is recruiting now.
Across all 22 studies, recruiting or not: 55% stop at 75 or younger and 55% at 65; 91% take children; 0% are for women only and 0% for men only; 18% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 22 of 22. search them.
- Cold Atmospheric Plasma Device Extension StudyTerminatedNCT05937672Phase 31 country
- Study of a Cohort of Children With Molluscum Contagiosum (MC) Treated With a 5% Solution of Potassium Hydroxide (Molutrex®) Applied Locally to the SkinCompletedNCT056801811 country
- MC RCT - BPO vs AdapaleneWithdrawnNCT05536882Phase 31 country
- Comparative Efficacy of 10% Potassium Hydroxide Solution Versus Cryotherapy in Molluscum ContagiosumCompletedNCT05897112Phase 11 country
- A Study to Evaluate the Safety and Efficacy of SB206 in Subjects With Molluscum ContagiosumCompletedNCT03436615Phase 21 country
- A Phase 3 Efficacy & Safety of SB206 & Vehicle Gel for the Treatment of MCCompletedNCT03927703Phase 31 country
- A Phase 3 Molluscum Contagiosum Efficacy and Safety StudyCompletedNCT04535531Phase 31 country
- A Phase 3 Randomized Parallel Group Study Comparing the Efficacy & Safety of SB206 & Vehicle Gel in the Treatment of MC (B-SIMPLE1)CompletedNCT03927716Phase 31 country
- Comparison of 5% Potassium Hydroxide With 10% Potassium Hydroxide Solution in Treatment of Molluscum ContagiosumCompletedNCT05634460Phase 11 country
- Using a Cold Atmospheric Plasma Device to Treat Skin DisordersStatus unknownNCT02759900Not applicable1 country
- Picato for the Treatment of Molluscum Contagiosum in Immunocompromised PatientsWithdrawnNCT03336372Early Phase 11 country
- Cantharidin Application in Molluscum Patients-1CompletedNCT03377790Phase 31 country
- Cantharidin Application in Molluscum PatientsCompletedNCT03377803Phase 31 country
- Evaluation of Systemic Exposure to VP-102 in Subjects With Molluscum Contagiosum.CompletedNCT03186378Phase 21 country
- The Effectiveness of Oral Acyclovir in the Treatment of Molluscum Contagiosum in ChildrenStatus unknownNCT04476186Not applicable1 country
- Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of BergamoCompletedNCT02902822Not applicable1 country
- A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of Molluscum ContagiosumTerminatedNCT02024581Phase 21 country
- Safety and Efficacy of Topical Cantharidin for the Treatment of Molluscum Contagiosum, Phase 2CompletedNCT03017846Phase 21 country
- A Study of VBP-245 in Pediatric Patients With Molluscum ContagiosumCompletedNCT03077750Phase 21 country
- Safety and Efficacy Study of Topical Cantharidin for the Treatment of Molluscum ContagiosumCompletedNCT02665260Phase 2
- Efficacy and Tolerance of Potassium Hydroxide (10% and 15%) in Molluscum ContagiosumCompletedNCT01348386Phase 2/31 country
- Efficacy of Cantharidin in Molluscum ContagiosumCompletedNCT00667225Not applicable1 country